S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
暂无分享,去创建一个
S. Ambs | D. Wink | Jeffrey E. Green | C. Switzer | R. Cheng | L. Ridnour | S. Glynn
[1] D. Generali,et al. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. , 2012, Cancer treatment reviews.
[2] B. Gaston,et al. S-Nitrosylation signaling regulates cellular protein interactions. , 2012, Biochimica et biophysica acta.
[3] S. Ambs,et al. Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer. , 2011, Trends in pharmacological sciences.
[4] Hsien-Da Huang,et al. SNOSite: Exploiting Maximal Dependence Decomposition to Identify Cysteine S-Nitrosylation with Substrate Site Specificity , 2011, PloS one.
[5] O. Ogunwobi,et al. Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways , 2011, Clinical & Experimental Metastasis.
[6] J. Stamler,et al. Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2 , 2011, Cell.
[7] Mithat Gönen,et al. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. , 2011, The Journal of clinical investigation.
[8] J. Reis-Filho,et al. β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation , 2011, Modern Pathology.
[9] O. Johannsson,et al. Selection for EGFR gene amplification in a breast epithelial cell line with basal-like phenotype and hereditary background , 2011, In Vitro Cellular & Developmental Biology - Animal.
[10] A. Sbarbati,et al. Mesenchymal/Stromal Gene Expression Signature Relates to Basal-Like Breast Cancers, Identifies Bone Metastasis and Predicts Resistance to Therapies , 2010, PloS one.
[11] R. Stephens,et al. Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. , 2010, The Journal of clinical investigation.
[12] Shou-Ching Tang,et al. Triple-Negative Breast Cancer: Unique Biology and Its Management , 2010, Cancer investigation.
[13] Shuk-Mei Ho,et al. Comprehensive Identification and Modified-Site Mapping of S-Nitrosylated Targets in Prostate Epithelial Cells , 2010, PloS one.
[14] T. Senga,et al. S-Nitrosylation at Cysteine 498 of c-Src Tyrosine Kinase Regulates Nitric Oxide-mediated Cell Invasion* , 2009, The Journal of Biological Chemistry.
[15] M. Fishbein,et al. Proinflammatory Mediators Upregulate Snail in Head and Neck Squamous Cell Carcinoma , 2009, Clinical Cancer Research.
[16] J. Stamler,et al. Protein S-nitrosylation in health and disease: a current perspective. , 2009, Trends in molecular medicine.
[17] C. Fan,et al. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. , 2009, Cancer research.
[18] Simone Brabletz,et al. E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer , 2009, Cancer and Metastasis Reviews.
[19] Hajime Kuroda,et al. Basal cytokeratin expression in relation to biological factors in breast cancer. , 2008, Human pathology.
[20] W. Schiemann,et al. Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms. , 2008, Carcinogenesis.
[21] C. Harris,et al. The reemergence of nitric oxide and cancer. , 2008, Nitric oxide : biology and chemistry.
[22] S. Ambs,et al. Molecular mechanisms for discrete nitric oxide levels in cancer. , 2008, Nitric oxide : biology and chemistry.
[23] M. Ringnér,et al. The CD44+/CD24- phenotype is enriched in basal-like breast tumors , 2008, Breast Cancer Research.
[24] Ian O Ellis,et al. Basal-like breast cancer: a critical review. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] W. Hahn,et al. Multiple pathways regulated by the tumor suppressor PP2A in transformation. , 2008, Trends in molecular medicine.
[26] Samuel Leung,et al. Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype , 2008, Clinical Cancer Research.
[27] G. Moreno-Bueno,et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.
[28] A. Tutt,et al. Triple negative tumours: a critical review , 2007, Histopathology.
[29] Charles M Perou,et al. EGFR associated expression profiles vary with breast tumor subtype , 2007, BMC Genomics.
[30] J. Foidart,et al. β-Catenin and ZO-1: Shuttle Molecules Involved in Tumor Invasion-Associated Epithelial-Mesenchymal Transition Processes , 2007, Cells Tissues Organs.
[31] J. M. Robinson,et al. Membrane "lens" effect: focusing the formation of reactive nitrogen oxides from the *NO/O2 reaction. , 2007, Chemical research in toxicology.
[32] James B. Mitchell,et al. Superoxide Fluxes Limit Nitric Oxide-induced Signaling* , 2006, Journal of Biological Chemistry.
[33] D. Wink,et al. The biphasic nature of nitric oxide responses in tumor biology. , 2006, Antioxidants & redox signaling.
[34] C. Perou,et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.
[35] Roman Rouzier,et al. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy , 2005, Clinical Cancer Research.
[36] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] Solomon H. Snyder,et al. The Biotin Switch Method for the Detection of S-Nitrosylated Proteins , 2001, Science's STKE.
[39] D. Wink,et al. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. , 2001, Nitric oxide : biology and chemistry.
[40] A. Buzaid,et al. Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] D. Wink,et al. Nitrosative Capacity of Macrophages Is Dependent on Nitric-oxide Synthase Induction Signals* , 2000, The Journal of Biological Chemistry.
[42] Xiaoping Liu,et al. Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[43] C. Estrada,et al. Nitric oxide reversibly inhibits the epidermal growth factor receptor tyrosine kinase. , 1997, The Biochemical journal.
[44] J. Chen,et al. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. , 1992, Science.
[45] O. Olopade,et al. Stem Cells , Tissue Engineering and Hematopoietic Elements Wnt /-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome , 2010 .
[46] C. Harris,et al. Nitric Oxide and Cancer: An Overview , 2010 .
[47] B. Bonavida. Nitric oxide (NO) and cancer , 2010 .
[48] R. Bernards,et al. Protein phosphatase 2A regulatory subunits and cancer. , 2009, Biochimica et biophysica acta.